Meyka Pro banner
Sernova Corp.

Sernova Corp. Fundamental Analysis (TSX: SVA.TO)

SVA.TOTSX
HealthcareBiotechnology
$0.11
$0.00(0.00%)
Canadian Market opens in 14h 45m

Sernova Corp. Fundamental Analysis (TSX: SVA.TO)

Sernova Corp. (TSX: SVA.TO) shows moderate financial fundamentals with a PE ratio of -3.28, profit margin of 0.00%, and ROE of 55.85%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

ROE55.85%
PEG Ratio-0.04

Areas of Concern

Operating Margin0.00%
Cash Position2.73%
Current Ratio0.14
We analyze SVA.TO's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 54.0/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.

Fundamental Health Score

C
54.0/100

We analyze SVA.TO's fundamental strength across five key dimensions:

Efficiency Score

Weak

SVA.TO struggles to generate sufficient returns from assets.

ROA > 10%
-7.71%

Valuation Score

Excellent

SVA.TO trades at attractive valuation levels.

PE < 25
-3.28
PEG Ratio < 2
-0.04

Growth Score

Weak

SVA.TO faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

SVA.TO shows balanced financial health with some risks.

Debt/Equity < 1
-0.25
Current Ratio > 1
0.14

Profitability Score

Weak

SVA.TO struggles to sustain strong margins.

ROE > 15%
55.85%
Net Margin ≥ 15%
0.00%
Positive Free Cash Flow
No

Key Financial Metrics

Is SVA.TO Expensive or Cheap?

P/E Ratio

SVA.TO trades at -3.28 times earnings. This suggests potential undervaluation.

-3.28

PEG Ratio

When adjusting for growth, SVA.TO's PEG of -0.04 indicates potential undervaluation.

-0.04

Price to Book

The market values Sernova Corp. at -4.19 times its book value. This may indicate undervaluation.

-4.19

EV/EBITDA

Enterprise value stands at -4.11 times EBITDA. This is generally considered low.

-4.11

How Well Does SVA.TO Make Money?

Net Profit Margin

For every $100 in sales, Sernova Corp. keeps $0.00 as profit after all expenses.

0.00%

Operating Margin

Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.

0.00%

ROE

Management delivers $55.85 in profit for every $100 of shareholder equity.

55.85%

ROA

Sernova Corp. generates $-7.71 in profit for every $100 in assets, demonstrating efficient asset deployment.

-7.71%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $-0.02 in free cash annually.

$-0.02

FCF Yield

SVA.TO converts -12.66% of its market value into free cash.

-12.66%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-3.28

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.04

vs 25 benchmark

P/B Ratio

Price to book value ratio

-4.19

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-0.25

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.14

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.56

vs 25 benchmark

ROA

Return on assets percentage

-7.71

vs 25 benchmark

ROCE

Return on capital employed

1.09

vs 25 benchmark

How SVA.TO Stacks Against Its Sector Peers

MetricSVA.TO ValueSector AveragePerformance
P/E Ratio-3.2832.02 Better (Cheaper)
ROE55.85%569.00% Weak
Net Margin0.00%29948.00% Weak
Debt/Equity-0.250.53 Strong (Low Leverage)
Current Ratio0.145.67 Weak Liquidity
ROA-771.32%-98.00% (disorted) Weak

SVA.TO outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Sernova Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ